Therefore, IF1 overexpression in breast cancer cells seems to promote the maintenance of ECM and tissue integrity diminishing their tumorigenic potential in agreement with the observed less migrating and invasive phenotype and consistent with the observation that IF1 overexpression is a biomarker of better prognosis in breast cancer patients (21). This evidence concerns the gene ATP5IF1 and breast carcinoma.